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Abstract: Phage therapy is an alternative treatment to antibiotics that can overcome multi-drug
resistant bacteria. In this study, we aimed to isolate and characterize lytic bacteriophages targeted
against Enterococcus faecalis isolated from root canal infections obtained from clinics at the Faculty
of Dentistry, Ismalia, Egypt. Bacteriophage, vB_ZEFP, was isolated from concentrated wastewater
collected from hospital sewage. Morphological and genomic analysis revealed that the phage belongs
to the Podoviridae family with a linear double-stranded DNA genome, consisting of 18,454, with
a G + C content of 32.8%. Host range analysis revealed the phage could infect 10 of 13 E. faecalis
isolates exhibiting a range of antibiotic resistances recovered from infected root canals with efficiency
of plating values above 0.5. One-step growth curves of this phage showed that it has a burst size
of 110 PFU per infected cell, with a latent period of 10 min. The lytic activity of this phage against
E. faecalis biofilms showed that the phage was able to control the growth of E. faecalis in vitro. Phage
vB_ZEFP could also prevent ex-vivo E. faecalis root canal infection. These results suggest that phage
vB_ZEFP has potential for application in phage therapy and specifically in the prevention of infection
after root canal treatment.
Keywords: Enterococcus faecalis; bacteriophage; phage therapy; root canal infection; multi-drug resistant
1. Introduction
The main goal of endodontic treatment is thorough disinfection of the root canal sys-
tem, followed by the application of an adequate three-dimensional tight seal to prevent bac-
terial re-colonization and promote the healing of periradicular tissues [1]. Post-treatment
apical periodontitis is an infectious disease in root canal-treated teeth caused mainly by
persistent intra-radicular infection. Enterococcus faecalis, a commensal Gram-positive mi-
croorganism, is frequently recovered from secondary persistent infections associated with
root canal treatment failures [2,3]. Persistent infection can result in invasion of periradicular
tissues with the subsequent development of apical periodontitis and /or diffused infection
(cellulitis) [4]. The reason for post-treatment disease is largely attributed to the limitations of
the present intra-canal disinfection protocols to combat intracanal E. faecalis infection [2,3].
The instrumentation is incapable of touching all the infected canal walls. Anatomically chal-
lenging areas include lateral canals, isthmi, apical ramifications, and dentinal tubules [5,6].
Moreover, attacking mature microbial biofilms with conventional antibiotics has limited
efficacy, requiring much higher drug doses than usual. Bacteria residing in biofilms are
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frequently inaccessible to antibacterial agents and are afforded protection from the immune
system. Biofilms therefore constitute a reservoir of bacteria that can be disseminated to
establish chronic infections throughout the body [7]. E. faecalis is hard to eradicate, and
especially from root canals [8,9]. E. faecalis lodged in recalcitrant biofilms are involved in
the failure of endodontic treatments and antibacterial treatments [10,11]. Conventional
antibacterial rinsing with chlorhexidine or sodium hypochlorite can enhance E. faecalis
adaptation and growth in the presence of calcium hydroxide in intracanal dressings [12–14].
E. faecalis have a variety of virulence factors reported to be responsible for pathogenic-
ity, including biofilm formation and the expression of surface adhesion components such as
enterococcal surface protein (ESP), endocarditis-associated antigen, and capsular polysac-
charides [15–18]. The expression of metalloprotease gelatinase E gene has been associated
to higher biofilm production in E. faecalis recovered from root canal infections [19]. Cy-
tolysin expression is also related to observations of pathogenicity in animal models of
infection and is associated with mortality in human bacteremia patients [20–22].
Enterococci have emerged as a major cause of hospital-acquired infections that are
difficult to treat due to intrinsic and acquired resistance to multiple antimicrobial com-
pounds [23]. An increasing number of clinical cases are complicated by multi-drug resistant
(MDR) bacteria, which has prompted a re-examination of phage therapy to combat and
destroy these bacteria. There are several reasons why phage therapy can be more effi-
cient than antibiotics in the eradication of MDR bacteria [24–27]: 1, the high specificity
of phage for their host without impacting the normal microbiota [28], 2, the self-limiting
nature of phage as it is multiplication is dependent on the presence and growth of the
target bacteria [29], 3, the ability to refresh therapeutic phage preparations to retarget any
bacteria surviving therapy to achieve eradication [30], 4, the efficacy of phages to penetrate
and disrupt biofilms [31], and 5, the ease of isolating new phages from different sources
and the low cost of developing phage preparations compared to the production of new
antibiotics [32,33]. The isolation of new phages is important to widen the spectrum of
phage activities and enhance applications to treat MDR bacteria emerging in therapy or
decontamination applications [34,35].
The aims of this study were to isolate and characterize anti E. faecalis phage to evaluate
phage lytic activity against E. faecalis biofilms, and to assess its therapeutic potential to
prevent E. faecalis infection in dental treatments of root canals by using an ex vivo human
root canal model.
2. Materials and Methods
2.1. Isolation and Identification of E. faecalis from Root Canal
2.1.1. Patient Selection
One hundred and fifty patients were selected to join this study from the endodontic
clinic at the faculty of Dentistry, Suez Canal University, Egypt, after the approval of Ethics
Committee of the University, and a written informed consent obtained from all patients
after explanation of the study procedure. All selected patients did not suffer of any chronic
systemic illness and had not received antibiotic therapy within the previous 3 months. The
patients selected had post-treatment apical periodontitis in a single rooted tooth. Teeth with
an un-restorable coronal tooth structure, vertical root fractures, and periodontal pockets
more than 4-mm deep were excluded from the study.
2.1.2. Sampling Procedures
Strict aseptic technique was applied during sampling. Scaling was undertaken to
remove any plaque or calculus. The tooth was polished with pumice and 3% hydrogen
peroxide. Rubber dam isolation was performed; caries and/or coronal restorations were
removed with sterile high-speed burs. Sterile saline was used as coolant and high suction
was applied. The operative field, including the tooth, clamp, and surroundings, were
disinfected using 30% (v/v) hydrogen peroxide and 2.5% (w/v) NaOCl. Access opening
was achieved with new sterile burs, after which the operative field including the pulp
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chamber was cleaned and disinfected once again. NaOCl was neutralized with 5% (w/v)
sodium thiosulfate (Sigma-Aldrich, St Louis, MO, USA), and sterility control samples
(SR1) were taken from the tooth surface using a sterile Omni Swab with an ejectable head
(Whatman FTA, Sigma-Aldrich). The swab was transferred to a cryotube containing Tris-
EDTA buffer (10 mM Tris-HCL, 1 mM EDTA, pH 7.6) (Sigma-Aldrich) and immediately
placed in a Labtop cooler (−20 ◦C Nalgene Labtop cooler, Sigma-Aldrich) or directly to a
freezer (−80 ◦C). Samples in the Labtop cooler were later transferred to a freezer. Sterility
control samples were required to be uniformly negative after culturing on Bile Esculin
Azide agar selective medium (Sigma-Aldrich) for the detection of E. faecalis. The coronal
two thirds of the root fillings were mechanically removed with H-type hand files (Dentsply
Maillefer, Ballaigues, Switzerland) and Fanta blue rotary orifice opener files (Fanta, Plano,
TX, USA). The canal was filled with sterile saline solution with care to not overflow; a
new sterile #15 K-file (Dentsply Maillefer) was inserted 1-mm short of the apical foramen
with the help of the Root ZX electronic apex locator (J Morita Corp, Tokyo, Japan) with
confirmation by radiograph; then a gentle filing motion was applied. Successive larger
endodontic files were used to engage the root canal filling material. On withdrawal from
the canal, the instrument was cut with a sterilized wire cutter, and the fragment with
attached root filling material was put in a cryotube. In addition, the root canal walls
were filed with sterile saline without suction, and the entire canal content was absorbed
onto 3 sterile paper points that were inserted to the full working length that left for about
1 min. The paper points were then transferred to Tris-EDTA buffer. Apical preparation
was completed to the working length with Fanta blue rotary files (Fanta, USA) and hand
nickel-titanium files (NitiFlex, Dentsply Maillefer) with sterile saline irrigation. Master
apical files ranged from #40 to #60 depending on both the root anatomy and the initial
diameter of the root canal was reached. Other samples were taken from the canal lumen
using sterile paper points as described earlier. Samples (paperpoints) were collected in
sterile universal tubes containing 5 mL saline and 1% (w/v) yeast extract and transported
to laboratory and immediately diluted before culturing on Bile Esculin Azide agar medium
(Sigma-Aldrich, St Louis, MO). The root canal was then irrigated with 2.5% (w/v) NaOCl
using ultrasonic activation and 2% cycloheximide (w/v) as final rinse [36,37]. The canal
was dried, and obturated with gutta-percha and AH Plus sealer (Dentsply) using the cold
lateral compaction technique [38]. The tooth access was sealed with composite restoration,
and a final radiograph was taken. Black colonies were collected for further biochemical
and molecular identification at Animal Health Research Institute, Dokki, and Giza, Egypt.
Stock cultures were stored in LB broth containing 20% (v/v) glycerol at −20 ◦C.
2.2. Biochemical Identification of E. faecalis
Presumptive colonies of E. faecalis were Gram stained and tested for catalase. Iden-
tification was confirmed using API 20 STREP strip systems (Biomerieux, Cairo, Egypt),
according to manufacturer’s recommendations, and the VITEK system, according to manu-
facturer´s recommendations at the Biotechnology unit, Animal Health Research Institute,
Dokki, Giza, Egypt.
2.3. Antimicrobial Susceptibility Test
Antimicrobial susceptibility testing was performed using the minimal inhibitory
concentration (MIC) method by using the VITEK system, located at the Biotechnology unit,
Animal Health Research Institute, Dokki, Giza, Egypt. MICs of ampicillin, penicillin G,
ciprofloxacin, levofloxacin, erythromycin, quinupristin⁄dalfopristin, linezolid, vancomycin,
tetracyclin, tigecycline, nitrofurantoin, gentamycin and streptomycin were interpreted
according to Clinical Laboratory Standard Institute (CLSI) guidelines, 2015 [39].
2.4. PCR Analysis of E. faecalis Genomic DNAs
DNA extraction from samples was performed using the QIAamp DNA Mini kit
(Qiagen, Düsseldorf, Germany, GmbH) with modifications from the manufacturer’s rec-
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ommendations. Briefly, 200 µL of the sample suspension was incubated with 20 µL of
proteinase K and 200 µL of lysis buffer at 56 ◦C for 10 min. After incubation, 200 µL of 100%
ethanol was added to the lysate. The sample was then centrifuged and washed following
the manufacturer’s recommendations. Nucleic acid was eluted with 100 µL of elution
buffer provided in the kit. PCR amplification of 16S rRNA gene was performed as de-
scribed previously [37] using the forward primer 5′-GTTTATGCCGCATGGCATAAGAG-3′
and reverse primer 5′-CCGTCAGGGGACGTTCAG-3′ (Midland Certified Reagent Com-
pany, Midland, TX, USA). Six oligonucleotide primer pairs (Midland Certified Reagent
Company) were used to amplify the genes encoding the aggregation substances protein
(asa1), gelatinase (gelE), cytolysin (cylA), surface protein (esp), collagen binding protein (ace)
and surface antigen (EF3314) for E. faecalis, as described previously [40,41]. The primer
sequences and expected amplicon sizes are listed in Supplementary Table S1. PCR was
carried out in a 25 µL reaction containing 12.5 µL of EmeraldAmp Max PCR Master Mix
(Takara, Japan), 1 µL of each primer (20 pmol), 4.5 µL of water, and 6 µL of DNA template
(30 ng). The reactions were performed in an Applied Biosystems 2720 thermal cycler
(Biometra, Göttingen, Germany). The products of PCR were separated by electrophoresis
on 1.5% agarose gel (Applichem GmbH, Germany) in 1x TBE buffer (10.78 g/L Tris buffer,
5.5 g/L Boric acid, 0.82 g/L EDTA, pH 8.3) at room temperature using gradients of 5 V/cm.
For gel analysis, 20 µL of the products was loaded in each gel slot. A Gelpilot 100 bp
Ladder (Qiagen GmbH, Germany) was used to determine the fragment sizes. The gel was
photographed by a gel documentation system (Alpha Innotech, Biometra) and the data
was analyzed using associated software [37].
2.5. Isolation of Bacteriophages Infecting E. faecalis
Bacteriophages were isolated from different sewage water samples obtained from
Zagazig City, Egypt by the enrichment technique [42]. The sewage samples were clarified
by centrifugation at 6000× g. for 20 min, after particle removal by paper filters, the water
sample was filtrated through 0.45-µm pore membranes. Then, a 100 mL of the filtrate was
added to an equal volume of 2× TSB (Tryptic Soy Broth; Oxoid, UK) medium and 1 mL
of log phase culture of different isolated E. faecalis (3 × 108 CFU/mL) and incubated in a
shaking incubator 120 rpm at 37 ◦C for 24 h. The culture was then centrifuged at 6000× g.
for 10 min, treated with chloroform and the supernatant filtered through 0.45 µm pore
membranes to remove the bacterial culture, and the supernatant was used as a source of
possible phages to be detected on the propagative strain. Bacterial lawns of E. faecalis were
poured over the surface of TSA (Tryptic Soy Agar; Oxoid, UK) plates using the double agar
overlay technique, as described by Adams [42]. Briefly, 100 µL of a mid-exponential phase
of bacterial culture was added to 3 mL semi-solid TSA and poured over solid TSA agar
plates. After drying, 15 µL droplets of the possible phage source previously prepared were
spotted onto the lawns and left to dry. The plates were incubated overnight at 37 ◦C and
checked for the presence of lysis zones.
2.6. Bacteriophages Purification and Propagation
Bacteriophages were propagated and purified from single plaque isolates according
to previous studies [42,43]. Phage isolates were purified by picking three successive single
plaques using a sterile Pasteur pipette until homogenous plaques were obtained. Briefly, a
single plaque was picked and put into 5.0 mL nutrient broth containing 100 µL of bacterial
host and then incubated at 37 ◦C under shaking condition with 1200 rpm. After incubation,
chloroform was added and the phage-host mixture centrifuged at 6000× g. for 10 min
and the supernatant was filtered through a sterilized 0.45-µm Millipore filter (Steradisc,
Kurabo Co., Ltd. Osaka, Japan) before filtration with 0.22-µm Millipore filter. The purified
phage was stored at 4 ◦C.
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2.7. Determination of Host Range and Cross Infectivity of the Isolated Bacteriophages
The isolated phage was investigated for host range specificity and lysis efficiency.
Bacterial lawns off different bacterial species were propagated on TSA plates as described
before, and 10-µL droplets of phage were spotted on the lawns. The plates were incubated
at 37 ◦C for 24 h and checked for the presence of plaques. To assess the host-range of the iso-
lated phage, Streptococcus mutans, Enterococcus gallinarum, Enterococcus faecium, Escherichia
coli, Pseudomonas aeruginosa, and Staphylococcus aureus were each inoculated on double-
layered agar plates containing the appropriate medium, and streak tests were performed.
2.8. Efficiency of Plating (EOP)
Bacteriophage vB_ZEFP was tested in triplicate over eight decimal dilutions against
all the susceptible bacterial strains lysed in the spot assays, as previously described [44].
Conditions of these experiments were similar to the conditions of the spot tests. Thus,
200 µL of all bacterial isolates in Log-phase bacteria were added to top agar, and different
dilutions of phages were spotted on the surface of petri dishes containing the bacterial host.
The plates were incubated overnight at 37 ◦C and the EOP was estimated as the average
PFU on target bacteria/average PFU on host bacteria.
2.9. Determination of the Frequency of Bacteriophage Insensitive Mutants
The frequency of the emergence of bacteriophage insensitive mutants (BIMs) was
estimated. Phage vB-ZEFP was mixed with bacterial host strains that were confirmed
to be susceptible to the bacteriophage at an MOI of 10. After 10 min of incubation at
37 ◦C, the suspension was serially diluted and spotted using double agar overlay plaque
assays. Plates were incubated overnight. The survivors of phage infection were calculated
correspondingly by dividing bacterial viable counts remained after phage infection by
initial viable counts. Experiments were conducted in triplicate.
2.10. Examination of Phage Morphology by Electron Microscopy
Bacteriophage particles were stained with Na-phosphotungstate or uranyl acetate
before observation in a Hitachi H600A electron microscope, as described previously [43]. A
drop of phage suspension at high titer (1011 PFU/mL) was placed on 200 mesh copper grids
with carbon-coat formvar films, and any excess drawn off by absorption to filter paper. A
saturated solution of Na-phosphotungstate or uranyl acetate was then placed on the grids
and the excess drawn off as before. Specimen was examined with an electron microscope
in a Hitachi H600A electron microscope, Faculty of Agriculture, Mansoura University.
2.11. Assessment of Phage Lytic Activity in Biofilms
The activity of isolated phage against established biofilms of E. faecalis 4 was deter-
mined using the microtitre plate assay as previously described [45]. Briefly, the bacterial
culture broth was diluted 1:100 in LB. (Oxoid, UK) and loaded into the wells of untreated
96-well polystyrene flat-bottom microtitre plate (Costar, Corning Inc., Corning, NY, USA).
The plates were then incubated at 37 ◦C for 24 h under gentle shaking to allow biofilm
formation. Unattached planktonic cells were carefully removed by washing twice in 0.9%
(w/v) NaCl. Using MOIs 0.1, 1, and 10, phage was diluted in LB and added to each well
1 day after the biofilm established, whilst saline solution was added to other wells as
a control. The plates were incubated for 24 h at 37 ◦C. The biofilms were washed with
0.9% NaCl, and the biofilm biomass quantified by staining with crystal violet (1% w/v)
for 20 min. Following washing with 0.9 NaCl solutions, the crystal violet was solubilized
in ethanol (95%) and then, the absorbance was measured using an ELISA plate reader
at OD600.
2.12. One-Step Growth Curve
One step growth experiments were performed as previously described [46]. Briefly,
E. faecalis strains were grown at OD = 0.2 (~108 CFU/mL) and infected with bacteriophage
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at MOI of 0.1 and then, allowed to adsorb for 10 min at room temperature. The mixture was
centrifuged, and the pellets re-suspended in 10 mL of LB medium and incubated at 37 ◦C.
Samples (200 µL each) were obtained at 5-min intervals and divided into two volumes of
100 µL. The first sample (without the addition of chloroform) was immediately diluted
and plated for phage titration to enumerate the phage particles released from the infected
bacterial cells, while chloroform was added to the other sample at a concentration of 1%
(v/v) to release the intracellular phages in order to determine the eclipse period.
2.13. Bacteriophage Temperature and pH Stability
The temperature stability of phage was estimated at different temperatures (40, 50,
60, 70, 80, 90, and 100 ◦C) over 1 h. Samples were obtained at 10 min intervals, and
immediately diluted and plated for phage titration [47]. The stability of phage at different
pH values (2, 4, 6, 8, 10, 12, and 13) was determined using SM phage buffer (5.8 g of NaCl,
1.2 g of MgSO4, 50 mL of 1 M Tris-HCl pH 7.5 with 0.1 g of gelatin in 1000 mL of deionized
water) and the pH adjusted by the addition of 1 M HCl or 1 M NaOH solutions. After
incubation of the mixtures at 4 ◦C overnight, the residual phage activity was determined
by plaque assay technique, as previously reported [46].
2.14. Isolation and Characterization of Nucleic Acids from Phage Particles
Phage DNA was extracted using a phenol/chloroform method [48]. Briefly, 200 µL of
purified suspension was treated with lysis buffer (0.5% (w/v) SDS, 100 µg/mL proteinase
K, 20 mM EDTA) for 1 h at 56 ◦C. An equal volume of phenol: chloroform: isoamyl alcohol
(25:24:1) was added to remove proteinaceous material. Extraction was repeated twice, and
between each step the upper aqueous phase layer was transferred into a new phage-lock
gel tube and gently vortexed. The mixture was centrifuged at 10,000× g at 4 ◦C for 5 min.
The supernatant was transferred to a new sterile 1.5 mL Eppendorf tube and DNA was
precipitated by adding an equal volume of isopropanol and the mixture allowed to stand
at −20 ◦C overnight. The DNA pellet was centrifuged at 10,000× g at 4 ◦C for 20 min and
washed twice with 75% (v/v) ethanol and suspended in deionized water before storage
at −20 ◦C. The DNA was digested with restriction enzymes BamHI, EcoRI and HindIII
according to the supplier’s instructions (Takara Bio Inc., Kusatsu, Shiga, Japan). Conditions
and buffers were chosen according to the manufacturer’s instructions. The incubation
times for the restriction enzymes were 2 to 4 h. The digested DNA sample was analyzed by
electrophoresis at 100 V in a 1.0% (w/v) agarose gel stained with ethidium bromide using a
DNA ladder as marker.
2.15. Phages Genome Sequencing
DNA sequencing was performed using the Illumina MiSeq platform. Library prepa-
ration of vB_ZEFP genomic DNA followed the Illumina Nextera tagmentation protocol
(Illumina, Cambridge, United Kingdom) and the library sequenced using the Illumina v3
sequence cassette for 600 cycles on the MiSeq. The data consisted of 1.1 and 3.4 million
paired-end sequence reads of 60 to 250 bp in length for vB_ZEFP. Initial processing of the
raw data and de novo assembly was performed using CLC Genomics Workbench version
11.0.1 (Qiagen, Aarhus, Denmark). The assembled reads yielded double-stranded linear
DNA genome of 18,454 bp for vB_ZEFP. Gene predictions were made using PHASTER [49],
HHpred [50] and BLAST (Non-redundant NCBI databases; [51]) to identify putative open
reading frames (ORFs), followed by manual curation and polishing with Artemis [52].
The sequence is available under the GenBank accession number MT747434. Phylogenetic
analysis was performed from pairwise alignments generated by BLASTN [51] using the
fast minimum evolution method of Despr and Gascuel [53].
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2.16. Ex Vivo Human Root Canal Model
2.16.1. Tooth Selection and Preparation
Eighty extracted single-rooted teeth were collected from an outpatient clinic, Faculty
of Dentistry, Suez Canal University, after the approval of the faculty ethics committee. Only
teeth with a type I root canal were included in the study and teeth with open apexes, cracks
or apical ramifications were excluded. Teeth were cleaned from any debris by scaler and
disinfected with 2.5% (w/v) NaOCl. The crown was removed using sterile rotary disk
associated with coolant at the cemento-enamel junction level. The roots were painted with
two layers of nail varnish to seal the root periphery except the apical foramen.
Standard endodontic access cavity was undertaken using a sterile bur with coolant.
Patency was checked with #15 k-file (Micro Mega, Besancon, France) to the working length
(1 mm from the apex). Canal orifice was opened and flared using Fanta rotary orifice
opener files (Fanta, USA). All teeth were autoclaved for sterilization and kept in sterile
laminar flow.
2.16.2. Tooth Contamination and Obturation
Canals were treated by injection of E. faecalis suspensions (200 µL from a culture
with an OD600 of 0.1) in the coronal orifice of each tooth. Teeth were randomly divided
into four groups (n = 20). Shaping of the contaminated canals was achieved using K-files
(Micro Mega, Besancon, France) and Fanta rotary files (Fanta, USA), whilst cleaning was
performed using the following irrigation protocols for each group:
Group A: saline irrigation as a negative control
Group B: 200 µL of phage (108 PFU/mL) irrigation
Group C: 2.5% NaOCl and 200 µL of phage (108 PFU/mL) irrigation
Group D: 2.5% NaOCl and 17% EDTA irrigation
After the third rotary file (AF3 25/06) shaping, the canals were re-contaminated with
an E. faecalis suspension. Final cleaning and shaping were performed up to AF4 35/04
followed by K-files (#40) as a master apical file coupled with the corresponding irrigation
protocol, EDTA cream (Micro Mega) was used as a final rinse. The canals were obturated
using lateral condensation technique with gutta-percha and an endodontic sealer (AH plus;
Dentsply, Germany). Bacterial leakage was assessed using a two-chamber bacterial leakage
model using LB. as previously reported [54,55]. The culture turbidity was estimated every
24 h, optical density was measured, and samples were plated to determine the viable count
(CFU/mL).
2.17. Statistical Analysis
Analytical statistics were calculated using ANOVA with GraphPad PRISM software.
A p-value of 0.05 or less was considered statistically significant in all cases.
3. Results
3.1. Prevalence of E. faecalis in Root Canals
A total of twenty (13.3%) E. faecalis confirmed isolates were recovered from one hundred
and fifty samples collected from oral cavity at the clinics at the faculty of Dentistry, Ismailia,
Egypt. Figure 1 shows the age distribution of individuals positive for oral E. faecalis.
3.2. Sensitivity of E. faecalis to Antibiotics
Bacterial isolates were tested for their susceptibilities to 13 antibiotics prescribed in
human medicine. The susceptibility or resistance of isolates to antibiotics was determined
by determining the minimal inhibitory concentration (MIC) using the VITEK system. The
antimicrobial susceptibility profiles of E. faecalis (Table 1) demonstrated marked differences
in the frequencies of antibiotic resistance. E. faecalis was sensitive to linezolid, vancomycin
and tigecyclin, but resistant to benzylpencillin, ampicillin, gentamycin, streptomycin,
ciprofloxacin, levofloxacin, erythromycin, tetracycline, nitrofurantoin, and streptgramins.
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This study indicated that the majority (16/20) of E. faecalis isolated from root canal infec-
tions were resistant to multiple antibiotics. For example, EF 2 was resistant to 7 out of
13 antibiotics (54%), while EF 4 is resistant to 10 out of 13 antibiotics (77%).
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3.3. Survey of Virulence Determinants in E. faecalis Isolates
A ur e f six virulence genes of E. faecalis isolate No. 4 by PCR amplification
(Supplementary Figure S1) revealed the presence of the genes encoding the collagen
binding protein (ace), aggregation substances protein (asa1), and gelatinase (gelE). However,
no amplification products were detected for the genes encoding cytolysin (cylA), surface
protein (esp) and surface antigen (EF3314).
3.4. Isolation of Bacteriophages
Bacteriophage sp ific to MDR E. faecalis was isolated from four sewage samples
collected from Zagazig University hospital, Sharkia Province, Egypt using the spot test
technique on double layer agar. Of the 4 samples collected only one showed phage activity
against E. faecalis (isolates no. 1, 2, 4, 5, 7, 8, 9, 10, 12 and 13) as the host. Selection of the
vB_ZEFP bacteriophage was undertaken upon serial passage according to their ability to
lyse a broad range of E. faecalis isolates, generate reproducible clear zones of lysis, and their
capability to replicate to produce high titers on the selected host over time. The phage was
plaque purified and amplified by plate lysis in preparation for characterization.
3.5. Morphological Characterization of Phages by Electron Microscopy
The morphology of vB_ZEFP was characterized using TEM after staining with uranyl
acetate. Based on electron micrographs (Figure 2), the vB_ZEFP phage has icosahedral
heads with short non-contractile tail, morphology typical of phage belonging to the Podoviri-
dae family. Phage vB_ZEFP had mean head dimensions of 43.4 ± 2.1 × 41.1 ± 1.8 nm,
while tail length was calculated to be 20 ± 0.5 nm.
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Table 1. Antibiotic sensitivity of E. faecalis root canal isolates.
Antibiotics
β-Lactams Aminoglycosides Quinolones Tetracycline Macrolides Streptogramins Glycopeptide Oxalidinone Macrobid MAR Index
PEN G AMP GEN STR CIP LVX TET TGC ERY Q-D VAN LZD NIT
EF.1 S S S S S S S S S S S S S 0
EF.2 S S R R R R R S R R S S S 0.54
EF.3 S S S S S S S S S S S S S 0
EF.4 R R R R R R R S R R S S R 0.77
EF.5 R R S S R R S S S S S S S 0.28
EF.6 S S R R R R R S S R S S S 0.42
EF.7 S S S S S S S S S S S S S 0
EF.8 R R S S R R R S R R S S S 0.5
EF.9 R S R R S S S S R S S S S 0.28
EF.10 S S S R R R S S R R S S S 0.35
EF.11 R S S S S S R S R S S S S 0.21
EF12 R S S R R R S S S S S S R 0.35
EF.13 s S R S R R S S S R S S S 0.28
EF.14 S S R S S S R S R R S S R 0.35
EF.15 S S S S S S S S S S S S S 0
EF.16 R R R R S S S S R S S S S 0.35
EF.17 R S R S R S S S S S S S S 0.21
EF.18 S S R R S S R S R R S S S 0.35
EF.19 R R S S R S S S S S S S S 0.28
EF.20 R R S S R R R S S S S S R 0.42
Total R % 10 (50%) 6 (30%) 9 (45%) 8 (40%) 11 (55%) 9 (45%) 8 (40%) 0 9 (45%) 8 (40%) 0 0 4 (20%)
Abbreviations are as follows: (R): Resistant (S): sensitive, MAR: Multi- drug resistant. PEN G: Benzylpenicillin G, AMP: Ampicillin, GEN: Gentamycin High Level (Synergy), STR: Streptomycin High Level
(Synergy), CIP: Ciprofloxacin, LVX: Levofloxacin, TET: Tetracyclin, TGC: Tigecyclin, ERY: Erythromycin, Q-D: Quinopristin⁄Dalfopristin, VAN: Vancomycin, LZD: Linezolid NIT: Nitrofurantoin. Therapeutic
Interpretation Guideline:CLSI M100-S25 (2015).
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3.6. Host Range and EOP of vB_ZEFP Phage
The host r e of the isolated phage was determin d using thirteen E. faecalis isolates,
and with laboratory strains of Enterococcus faecium, Enterococcus gallinarium, Streptococcus
mutans, E. coli, and Staphylococcus aureus (Supplementary Table S2). The results showed
th the vB_ZEFP phage c uld infect 10 of 13 E. aecalis is lates ed as hosts in this study,
indicating broad host coverage of the oral E. faecalis isolates. The results showed no lytic
effects on any of the alternative host species tested. The ability of vB_ZEFP phage to lyse
multiple E. faecalis was further assessed by examining the efficiency of plating (EOP). The
selected phage exhibited EOPs ≥ 0.5 for all E. faecalis examined isolates.
3.7. Frequency of Bacteriophage Insensitive Mutants
The development of BIMs could compromise the long-term effectiveness of using
phage as therapeutic agents. Assays were performed in vitro to determine the frequency at
which BIMs emerged at 37 ◦C. BIMs were recovered following high multiplicity infections
(10) of host bacteria with bacteriophage vB-ZEFP at 37 ◦C. The host survival frequency was
determined to be low at 4 × 10−7 ± 3 × 10−7.
3.8. Bacteriophage Activity Against E. faecalis Established in Biofilms
E. faecalis isolate 4 was allowed to form biofilms in microtitre plates and challenged
with phage at different MOIs. The wells were evacuated after 24 h and stained with crystal
violet before OD measurement of ethanol solubilized crystal violet using an ELISA plate
reader (Figure 3). The results showed that the phage preparation significantly reduced the
crystal violet stainable biofilm content compared to control (p < 0.003). The highest MOI of
10 produced the greatest reductions, exhibiting a significantly greater reduction compared
to MOIs 0.1 and 1 (p < 0.004).
3.9. Phage Growth Characteristics
Burst size and latent period were determined for vB_ZEFP phage by performing
one-step growth curves (Figure 4). Chloroform aids new phage particles to free from
bacterial cell wall. The phage produced estimated burst size of 110 PFU per infected cell
with a latent period of 10 min.
3.10. Bacteriophage Temperature and pH Stability
The stability of isolated phage at different temperature and pH values was investigated.
The results indicated that the phage titers were stable at approximately 108 PFU⁄ mL for
50 min at temperatures of 40 ◦C and 50 ◦C. At 60 ◦C, the phage titer decreased after 40 min
to 106 PFU/mL. The phage titer fell to 105 PFU/mL after 30 min at 70 ◦C. (Figure 5A) and
fell to 104 PFU/mL after 20 min at 80 ◦C. The results revealed activity and stability of the
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phages over a broad pH range of 4 to 10 with the optimum titer at pH 6. However, post
exposure to pH 2 and pH 12 the phage titer was undetectable. (Figure 5B).
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Figure 4. Single step growth curve. The grey line represents nascent phage without chloroform addi-
tion (PFU/mL), while the blue line represents phages released after chloroform addition (PFU/mL).
The phage titers are recorded as means and the error bars are± standard deviation of three replicates.
Microorganisms 2021, 9, 517 12 of 19




Figure 4. Single step growth curve. The grey line represents nascent phage without chloroform 
addition (PFU/mL), while the blue line represents phages released after chloroform addition 
(PFU/mL). The phage titers are recorded as means and the error bars are ± standard deviation of 
three replicates. 
3.10. Bacteriophage Temperature and pH Stability 
The stability of isolated phage at different temperature and pH values was investi-
gated. The results indicated that the phage titers were stable at approximately 108 PFU⁄ 
mL for 50 min at temperatures of 40 °C and 50 °C. At 60 °C, the phage titer decreased 
after 40 min to 106 PFU/mL. The phage titer fell to 105 PFU/mL after 30 min at 70 °C. 
(Figure 5A) and fell to 104 PFU/mL after 20 min at 80 °C. The results revealed activity and 
stability of the phages over a broad pH range of 4 to 10 with the optimum titer at pH 6. 
However, post exposure to pH 2 and pH 12 the phage titer was undetectable. (Figure 5B). 
 
Figure 5. (A) Temperature and (B) pH stability of E. faecalis phage vB_ZEFP. 
Panel A shows the thermal stability of phage vB_ZEFP exposed to temperatures 40 
to 80 °C and the phage titers measured at 10-min intervals. The dashed lines indicate 
where the phage titers fell below the level of detection (2 log10 PFU/mL). Panel B shows 
pH on stability of the vB_ZEFP phage. Phage suspensions were incubated at pH indi-
cated for 16 h at 30 °C. Phage titers are recorded as means ± standard deviation. 
Figure 5. (A) Temperature and (B) pH stability of E. faecalis phage vB_ZEFP.
Panel A shows the thermal stability of phage vB_ZEFP exposed to temperatures 40 to
80 ◦C d the phage tit rs measured at 10-min int r als. The dashed lines indicate where
the phage titers fell below the level of detection (2 log10 PFU/mL). P nel B shows pH on
stability of t e vB_ZEFP phage. P age suspensions were incubated at pH i dicated for
16 h at 30 ◦C. Phage titers are recorded as means ± standard deviation.
3.11. Phage Genome
Gel electrophoresis of the genomic DNA of vB_ZEFP phage indicated that the phage
genome to be approximately 18 kb with similar size products generated upon HindIII
restriction endonuclease digestion. DNA sequencing of the vB_ZEFP phage DNAs enabled
de novo assembly and accurate size determination of linear genomes of 18,454 bp (Genbank
accession MT747434) with G + C contents of 32.8%. BlastN searches of the non-redundant
database at NCBI revealed the phage genome to exhibit 86–92% nucleotide identity with
a group of enterococcal phages classified in the family Podoviridae, subfamily Picovirinae.
Figure 6 presents the phylogenetic relationships between the enterococcal Podoviridae.
The genome sequence contained 28 open reading frames, of which 15 could be ascribed
putative functions on the basis of BLASTP, Phaster, and HHPred database searches, whilst
13 remained as hypothetical proteins. Reading frames for which putative functional
information could be ascribed to the products appear in Table 2.
Un-rooted phylogenetic tree of Enteroccocal phage genome sequences that can be
ascribed to the Picovirinae subfamily of the Podoviridae. Phage vB_ZEFP is marked in
bold and positioned central to the clade. Genome sequences were pairwise aligned with
BLASTN and the tree constructed using the fast minimum evolution method of Despr
and Gascuel [53] with a maximum sequence difference of 0.75 to maximize the accuracy
of the groupings.
3.12. Ex Vivo Human Root Canal Model
Eighty E. faecalis (isolate 4) infected root canals were irrigated with four irrigants
(n = 20) in order to determine the most effective procedure against E. faecalis. The irrigants
were phage (vB_ZEFP), phage and NaOCl, NaOCl and EDTA, and a saline solution as a
control (Figure 7A). The efficacy of the irrigant was evaluated by measuring the turbidity
in LB. (OD) arising due to residual bacterial leakage. All treatments showed a reduction in
the OD compared to the control (p < 0.02; Figure 7B), which was confirmed by viable count
at the experimental end point of 72 h (p < 0.03; Figure 7C). Based on the irrigants ability
to suppress E. faecalis growth, we concluded that irrigation with phage was more efficient
in preventing leakage from the root apex compared to the other treatments. Irrigation
with phage and NaOCl was also better than NaOCl alone with the lowest viable counts
recorded for phage treated groups: phage only (2 × 102 CFU/mL), phage with NaOCl
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(3 × 104 CFU/mL), and NaOCl and EDTA (3 × 106 CFU/mL). In the future, phage may
be used with NaOCl to prevent root canal treatment failure instead of using high concen-
trations of NaOCl, which can affect the oral microbiota and the human immune system.
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Table 2. Phage vB_ZEFP ORFs with putative protein encoding functions.
CDS ORF Location (nt) Putative Function
1 172–342 hypothetical protein
2 344–712 hypothetical prot in
3 786–1136 single-stranded DNA-binding protein
4 1204–1383 hypothetical protein
5 1380–1544 hypothetical protein
6 1557–1721 hypothetical protein
7 1734–1886 hypothetical protein
8 1870–2292 hypothetical protein
9 2285–3526 terminase large subunit
10 3539–5887 DNA polymerase
11 5947–6117 hypothetical protein
12 6117–6323 hypothetical protein
13 6314–6487 hypothetical protein
14 6488–6727 transcriptional regulator
15 6724–7221 HNH homing endonuclease
16 7221–7406 putative transmembrane protein
17 7406–8824 CHAP domain-containing lysin
18 8943–9389 DNA binding protein
19 9406–10182c peptidoglycan recognition and hydrolase
20 10183–10575c hypothetical protein
21 10575–12329c tail fiber protein
22 12331–13119c distal tail protein
23 13131–14696c phosphodiesterase
24 14710–15246c hypothetical protein
25 15296–16342c phage capsid and scaffold
26 16358–17575c phage capsid and scaffold
27 17577–17747c capsid related protein
28 17842–18177c hypothetical protein
Nucleotide locations with suffix c indicate the reading frame is located on the complementary strand.
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every 24 h at OD600. Panel (C) shows viable counts after 72 h. Error bars indicate ± standard deviation of the mean.
Microorganisms 2021, 9, 517 15 of 19
4. Discussion
There is an increasing number of antibiotic-resistant E. faecalis strains encountered
in clinical settings, and the protection afforded by biofilm formation make treatments
such as antiseptic rinses or antibacterial dressings increasingly ineffective. To control
E. faecalis necessitates alternative methods to be developed and executed [56]. The use
of lytic bacteriophages is a promising application under consideration to fight multidrug
resistant E. faecalis strains and their biofilms [55]. In this study, we have isolated E. faecalis
from root canal infections and examined their antibiotic susceptibility patterns. Only 3
of 20 confirmed isolates were sensitive to all the antibiotics tested. Multi-drug resistance
was encountered in 15 of the 20 isolates with one strain resistant to 10 antibiotics out of
13 tested. The incidence of multi-drug resistance may be due to the general misuse of
antibiotics. We have investigated the presence of genes involved in E. faecalis virulence
and the biofilm formation in the isolates from dental root canal samples of patients with
chronic periodontitis. These revealed the presence of genes encoding the collagen binding
protein (ace), aggregation substances protein (asa1), and gelatinase (gelE), which several
studies have ascribed roles in adhesion and biofilm formation for E. faecalis [57,58].
In this study, a phage specific to E. faecalis was isolated from four sewage samples and
designated as vB_ZEFP. Transmission electron microscopy showed that the phage belonged
to the Podoviridae family with an icosahedral head and short tail. The genome sequence was
consistent with this classification and exhibited similarity to other phages recently reported
for E. faecalis [59,60] and falls within orthocluster VI in the comprehensive evaluation of
the available E. faecalis phage genome sequences by Bolocan et al., which they concluded
are suitable for phage therapy applications [61]. Bacteriophage host ranges impact on
their utility for phage therapy. A host range restricted to one species is desirable, because
it prevents collateral damage leaving the remainder of the host microbiome intact [62].
Phage vB_ZEFP was specific for E. faecalis, but could infect 10 out of 13 different strains
isolated from root canals. Phage vB_ZEFP is highly productive with a burst size of 110 per
infected cell and a latent period of 10 min, which makes it suitable for phage therapy
applications. The efficiency of plating was calculated as the ratio between bacteriophage
titer on clinical isolate to bacteriophage titer on the strain used to isolate and replicate the
bacteriophage. The selected phage exhibited EOPs ≥ 0.5 for all E. faecalis isolates examined.
This is indicative that vB_ZEFP phage is able to efficiently infect multiple target strains
to reduce the numbers of viable bacteria over a wide host range. The phage was stable
over a broad pH range (4 to 10) and at temperatures up to 50 ◦C with residual activity
detectable (4 log10 PFU/mL reduction) after 20 min exposure at 80 ◦C. E. faecalis strains
form biofilms, which increases their resistance to antibacterial treatments that include
traditional antibacterial rinsing solutions such as sodium hypochlorite and chlorhexidine
and enable the bacterium to grow in the presence of calcium hydroxide [63–65]. We tested
the ability of the vB_ZEFP phage to reduce pre-formed bacterial biofilms. The results
showed that the ability of phage to reduce the crystal violet stainable biofilm content. The
greatest reduction of E. faecalis biofilm was observed when the bacterial host was treated
with a phage for the MOI of 10 in comparison with the carrier-treated control.
Genomic analysis confirmed that vB_ZEFP phage belongs to the Podoviridae. The
phage contains a linear, double-stranded DNA genome of 18,454 bp with 28 open read-
ing frames. BLASTn analysis revealed that vB_ZEFP phage shares 92.51% identity with
vB_EfaP_IME195 E. faecalis phage, which has a linear double-stranded DNA genome of
18,607 bp annotated with 27 coding sequences [59]. Our phage differs from IME-EF1,
HEf13 and EFDG1 reported to infect oral E. faecalis. IME-EF1 and HEf13 belong to the
Siphoviridae family with linear double-stranded DNA genomes of 57,081 and 57,811 nu-
cleotides respectively [66,67]. EFDG1 has a DNA genome of 149,589 bp and is classified in
the Spounavirinae subfamily of the Myoviridae [54]. EFDG1 was also reported to reduce the
content of 2-week pre-formed biofilms, which is indicative of a general advantage of phage
therapy over conventional antibiotic treatments against bacteria embedded in biofilms,
which are considered a major obstacle to the ability of antibiotics to destroy bacteria [55].
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Analysis of the vB_ZEFP phage genome identified a CHAP domain lysin (CDS 17)
and a peptidoglycan recognition hydrolase (CDS 19) that mediate host cell lysis. Further
study of the activities of these proteins could facilitate the use of these enzymes to treat
bacterial infections in the future, and particularly as lysins may be more stable than phages.
The activity of the vB_ZEFP phage were further tested in root canal infections using ex vivo
two chamber bacterial leakage model of human teeth. Results of turbidity measurement
revealed a greater ability of vB_ZEFP phage to reduce bacterial leakage from the root apex
compared to other treatments. The enumeration of bacterial counts after 72 h confirmed
the reduction in viable bacteria for the phage treated groups compared to conventional
hypochlorite treatment. Moreover, vB_ZEFP phage proved to be effective when used in
combination with hypochlorite allowing for the use of dual therapies. Our results suggest
that this phage has potential for phage applications and efficacy in the prevention of
infection after root canal treatments.
Supplementary Materials: The following are available online at https://www.mdpi.com/2076-260
7/9/3/517/s1, Table S1: PCR primers and products for the detection of E. faecalis virulence genes;
Table S2: Host range of E. faecalis bacteriophages. Figure S1 Gel electrophoresis of PCR amplification
products of E. faecalis virulence genes.
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